Amrutanjan Health Care Limited , a prominent player in the healthcare sector, has announced impressive financial results for the quarter ended June 30, 2025, alongside key corporate updates.

Financial Highlights

The company reported a substantial 80% increase in profit after tax, reaching ₹831.12 lakhs for the quarter, compared to ₹461.56 lakhs in the same period last year. This significant growth was accompanied by a 12.3% rise in revenue from operations, which climbed to ₹9,404.57 lakhs from ₹8,373.60 lakhs year-on-year.

The financial performance for the quarter is summarized in the table below:

The company's basic earnings per share (EPS) also saw a significant improvement, standing at ₹2.87 compared to ₹1.60 in the previous year's quarter.

Segment Performance

Amrutanjan Health Care's unaudited financial results reveal segment-wise performance:

• OTC Products: Remained the largest contributor with revenue of ₹5,697.24 lakhs.
• Women's Hygiene: Generated revenue of ₹2,860.75 lakhs.
• Beverages: Contributed ₹776.01 lakhs to the total revenue.
• Others (including Pain Management Centre): Recorded ₹70.57 lakhs in revenue.

Corporate Updates

The company's Board of Directors convened on August 12, 2025, and approved several key decisions:

1. Annual General Meeting: The 88th Annual General Meeting (AGM) is scheduled for September 23, 2025, to be held via video conference.

2. Record Date: September 16, 2025, has been set as the record date for determining shareholder eligibility for voting at the AGM and for final dividend payment.

3. Share Transfer Closure: The share transfer register will be closed from September 17 to September 23, 2025 (both days inclusive).

4. Secretarial Auditor Appointment: M/s. SPNP & Associates, Practicing Company Secretaries, have been appointed as the Secretarial Auditor for a five-year term starting April 1, 2025, subject to shareholder approval at the upcoming AGM.

Management Commentary

While specific management comments were not provided, the robust financial performance indicates strong execution of the company's business strategies and effective management of market conditions.

Amrutanjan Health Care Limited continues to demonstrate resilience and growth in the competitive healthcare sector. The significant increase in profitability and steady revenue growth reflect the company's strong market position and operational efficiency. Investors and stakeholders will be keenly watching the upcoming AGM for further insights into the company's future strategies and dividend announcements.

Amrutanjan Health Care , a prominent player in the healthcare sector, has released its fourth quarter financial results, showcasing robust growth across key metrics. The company has also announced a dividend recommendation, signaling confidence in its financial position.

Revenue Growth

Amrutanjan Health Care reported a notable increase in its Q4 revenue, which rose to ₹1.35 billion from ₹1.27 billion in the same quarter of the previous year. This represents a year-over-year growth of approximately 6.30%, indicating the company's ability to expand its market presence and sales despite challenging market conditions.

Improved Profitability

The company's profitability metrics showed significant improvement:

• EBITDA: Increased to ₹177.00 million from ₹162.40 million year-over-year
• EBITDA Margin: Improved to 13.07% from 12.78%, reflecting enhanced operational efficiency
• Net Profit: Rose to ₹151.80 million from ₹136.60 million, marking a solid 11.13% increase

The improvement in EBITDA margin suggests that Amrutanjan Health Care has successfully managed its operational costs while growing its revenue. This efficiency has translated into a stronger bottom line, as evidenced by the double-digit growth in net profit.

Dividend Announcement

In a move that will likely please shareholders, Amrutanjan Health Care's board has recommended a final dividend of ₹2.60 per equity share. This dividend announcement underscores the company's commitment to delivering value to its shareholders and reflects management's positive outlook on the company's financial health and future prospects.

The dividend payout also indicates that Amrutanjan Health Care is maintaining a balance between reinvesting in the business for future growth and rewarding its shareholders for their investment.

Conclusion

Amrutanjan Health Care's Q4 results demonstrate the company's resilience and ability to grow in a competitive healthcare market. The combination of revenue growth, improved profitability, and a dividend announcement paints a picture of a company that is performing well and confident about its future trajectory. Investors and market watchers will likely keep a close eye on how Amrutanjan Health Care builds on this momentum in the coming quarters.